Ameritas Investment Partners’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156K | Hold |
3,848
| – | – | ﹤0.01% | 1461 |
|
|
2025
Q1 | $198K | Hold |
3,848
| – | – | 0.01% | 1270 |
|
|
2024
Q4 | $213K | Buy |
3,848
+244
| +7% | +$13.5K | 0.01% | 1283 |
|
|
2024
Q3 | $119K | Hold |
3,604
| – | – | ﹤0.01% | 1676 |
|
|
2024
Q2 | $98K | Buy |
3,604
+634
| +21% | +$17.2K | ﹤0.01% | 1741 |
|
|
2024
Q1 | $108K | Hold |
2,970
| – | – | ﹤0.01% | 1687 |
|
|
2023
Q4 | $60.1K | Buy |
2,970
+1,023
| +53% | +$20.7K | ﹤0.01% | 2052 |
|
|
2023
Q3 | $34.6K | Hold |
1,947
| – | – | ﹤0.01% | 2290 |
|
|
2023
Q2 | $35.2K | Buy |
1,947
+587
| +43% | +$10.6K | ﹤0.01% | 2248 |
|
|
2023
Q1 | $17.1K | Hold |
1,360
| – | – | ﹤0.01% | 2526 |
|
|
2022
Q4 | $21.3K | Hold |
1,360
| – | – | ﹤0.01% | 2539 |
|
|
2022
Q3 | $23K | Hold |
1,360
| – | – | ﹤0.01% | 2465 |
|
|
2022
Q2 | $19K | Buy |
1,360
+845
| +164% | +$11.8K | ﹤0.01% | 2575 |
|
|
2022
Q1 | $9K | Hold |
515
| – | – | ﹤0.01% | 2837 |
|
|
2021
Q4 | $12K | Hold |
515
| – | – | ﹤0.01% | 2846 |
|
|
2021
Q3 | $11K | Hold |
515
| – | – | ﹤0.01% | 2920 |
|
|
2021
Q2 | $15K | Hold |
515
| – | – | ﹤0.01% | 2854 |
|
|
2021
Q1 | $17K | Hold |
515
| – | – | ﹤0.01% | 2637 |
|
|
2020
Q4 | $21K | Buy |
+515
| New | +$21K | ﹤0.01% | 2450 |
|